1. GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma. (10th October 2021) Authors: Scatolini, M.; Patel, A.; Grosso, E.; Mello‐Grand, M.; Ostano, P.; Coppo, R.; Vitiello, M.; Venesio, T.; Zaccagna, A.; Pisacane, A.; Sarotto, I.; Taverna, D.; Poliseno, L.; Bergamaschi, D.; Chiorino, G. Journal: British journal of dermatology Issue: Volume 186:Number 1(2022) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma. (1st January 2022) Authors: Scatolini, M.; Patel, A.; Grosso, E.; Mello‐Grand, M.; Ostano, P.; Coppo, R.; Vitiello, M.; Venesio, T.; Zaccagna, A.; Pisacane, A.; Sarotto, I.; Taverna, D.; Poliseno, L.; Bergamaschi, D.; Chiorino, G. Journal: British journal of dermatology Issue: Volume 186:Number 1(2022) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. TRANSPERITONEAL LAPAROSCOPICAL ILIAC LYMPHADENECTOMY (TPLND) FOR TREATMENT OF MALIGNANT MELANOMA. Issue 1 (1st March 2003) Authors: Volpi, E.; Picciotto, F.; Zaccagna, A.; Siatis, D.; Mazzola, S.; Sismondi, P. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗